Submitted by Anonymous (not verified) on 16 January 2026 - 14:00
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 22, Status: Authorised